Kauliv
teriparatide
Osteoporosis
Osteoporosis, Postmenopausal
Date of authorisation:
Revision: 2
Last updated:
MedicineHumanAuthorised
Teriparatide Sun
teriparatide
Osteoporosis
Osteoporosis, Postmenopausal
Date of authorisation:
Revision: 2
Last updated:
MedicineHumanAuthorised
Terrosa
teriparatide
Osteoporosis
Date of authorisation:
Revision: 6
Last updated:
MedicineHumanAuthorised
Sondelbay
teriparatide
Osteoporosis
Date of authorisation:
Last updated:
MedicineHumanAuthorised
Movymia
teriparatide
Osteoporosis
Date of authorisation:
Revision: 10
Last updated:
MedicineHumanAuthorised
Forsteo
teriparatide
Osteoporosis
Osteoporosis, Postmenopausal
Date of authorisation:
Revision: 24
Last updated:
MedicineHumanAuthorised
EMEA-002824-PIP01-20 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Immunology-Rheumatology-Transplantation
PIP number: P/0097/2021
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Powder for solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Teriparatide Cinnagen
teriparatide
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application
Qutavina
teriparatide
Osteoporosis
Date of authorisation:
Last updated:
MedicineHumanWithdrawn
Livogiva
teriparatide
Osteoporosis
Date of authorisation:
Revision: 1
Last updated:
MedicineHumanAuthorised